TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Elexir Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
9,691
|
7,825
|
7,936 |
Financial expenses |
1
|
5
|
1 |
Earnings before taxes |
1,104
|
1,078
|
1,208 |
EBITDA |
1,116
|
1,094
|
1,241 |
Total assets |
4,089
|
3,144
|
2,977 |
Current assets |
3,771
|
3,079
|
2,909 |
Current liabilities |
1,182
|
864
|
790 |
Equity capital |
2,782
|
2,189
|
1,947 |
- share capital |
5
|
4
|
5 |
Employees (average) |
15
|
10
![]() |
10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
68.0%
|
69.6%
|
65.4% |
Turnover per employee |
646
|
782
|
794 |
Profit as a percentage of turnover |
11.4%
|
13.8%
|
15.2% |
Return on assets (ROA) |
27.0%
|
34.4%
|
40.6% |
Current ratio |
319.0%
|
356.4%
|
368.2% |
Return on equity (ROE) |
39.7%
|
49.2%
|
62.0% |
Change turnover |
1,843
|
532
|
1,345 |
Change turnover % |
23%
|
7%
|
20% |
Chg. No. of employees |
5
|
0
|
3 |
Chg. No. of employees % |
50%
|
0%
|
43% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.